Having trouble accessing articles? Reset your cache.

Proleukin interleukin2 data

An NIH study with Proleukin found that self-administered, subcutaneous therapy gave sustained increases in CD4 counts with less severe side effects than seen with intravenous infusion. As

Read the full 275 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE